{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:19:12Z","timestamp":1793060352561,"version":"4.5.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Despite the availability of effective vaccines, hepatitis B virus (HBV) is still a major health issue, and approximately 350 million people have been chronically infected with HBV throughout the world. Interferons (IFNs) are the key molecules in the innate immune response that restrict several kinds of viral infections <jats:italic>via<\/jats:italic> the induction of hundreds of IFN-stimulated genes (ISGs). The objective of this study was to confirm if interferon alpha-inducible protein 27 (IFI27) as an ISG could inhibit HBV gene expression and DNA replication both in cell culture and in a mouse model. In human hepatoma cells, IFI27 was highly induced by the stimulation of IFN-alpha (IFN-\u03b1), and it potentiated the anti-HBV activity. The overexpression of IFI27 inhibited, while its silencing enhanced the HBV replication in HepG2 cell. However, the knocking out of IFI27 in HepG2 cells robustly increases the formation of viral DNA, RNA, and proteins. Detailed mechanistic analysis of the HBV genome showed that a sequence [nucleotide (nt) 1715\u20131815] of the EnhII\/Cp promoter was solely responsible for viral inhibition. Similarly, the hydrodynamic injection of IFI27 expression constructs along with the HBV genome into mice resulted in a significant reduction in viral gene expression and DNA replication. In summary, our studies suggested that IFI27 contributed a vital role in HBV gene expression and replication and IFI27 may be a potential antiviral agent for the treatment of HBV.<\/jats:p>","DOI":"10.3389\/fmicb.2021.656353","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T04:43:50Z","timestamp":1617165830000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Antiviral Activity of Interferon Alpha-Inducible Protein 27 Against Hepatitis B Virus Gene Expression and Replication"],"prefix":"10.3389","volume":"12","author":[{"given":"Hafiz","family":"Ullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Sajid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangpeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Adnan","family":"Shereen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaohong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianmo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruidong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1749-6632.1980.tb20614.x","article-title":"Immune Interferon: Some Properties and Functions.","volume":"350","author":"Baron","year":"1980","journal-title":"Ann. N Y. Acad. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s00705-004-0489-2","article-title":"Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: Differential requirement for wild-type GTP binding domain.","volume":"150","author":"Carter","year":"2005","journal-title":"Brief Rep. Arch. Virol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-9-23","article-title":"Study of the expression levels of Hepatocyte nuclear factor 4 alpha and 3 beta in patients with different outcome of HBV infection.","volume":"9","author":"Chen","year":"2012","journal-title":"Virol. J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1365-2893.2005.00543.x","article-title":"Activation and function of hepatic NK cells in hepatitis B infection: An underinvestigated innate immune response.","volume":"12","author":"Chen","year":"2005","journal-title":"J. Viral. Hepat."},{"key":"B5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1089\/jir.2010.0105","article-title":"Emerging roles of FAM14 family members (G1P3\/ISG 6-16 and ISG12\/IFI27) in innate immunity and cancer.","volume":"31","author":"Cheriyath","year":"2011","journal-title":"J. Interf. Cytokine Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nm.3108","article-title":"Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses.","volume":"19","author":"Cho","year":"2013","journal-title":"Nat. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"A41","DOI":"10.1053\/ejpn.2002.0573","article-title":"The interferon system: An overview.","volume":"6","author":"De Andrea","year":"2002","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma.","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/hep.23011","article-title":"Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain.","volume":"50","author":"Gao","year":"2009","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"14392","DOI":"10.1128\/jvi.79.22.14392-14403.2005","article-title":"Genomic Analysis of Anti-Hepatitis B Virus (HBV) Activity by Small Interfering RNA and Lamivudine in Stable HBV-Producing Cells.","volume":"79","author":"Guo","year":"2005","journal-title":"J. Virol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"4345L","DOI":"10.1128\/JVI.03094-14","article-title":"Inhibition of Hepatitis B Virus Gene Expression and Replication by Hepatocyte Nuclear Factor 6.","volume":"89","author":"Hao","year":"2015","journal-title":"J. Virol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1099\/jgv.0.000647","article-title":"Inhibition of hepatitis B virus replication by activation of the cGAS-STING pathway.","volume":"97","author":"He","year":"2016","journal-title":"J. Gen. Virol."},{"key":"B13","first-page":"258","article-title":"Virus interference. I. The interferon.","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc. R. Soc. Lon. Ser. B Biol. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1365-2893.2006.00732.x","article-title":"Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.","volume":"13","author":"Itsui","year":"2006","journal-title":"J. Viral Hepat."},{"key":"B15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/S0198-8859(02)00751-6","article-title":"Natural type I interferon-producing cells as a link between innate and adaptive immunity.","volume":"63","author":"Kadowaki","year":"2002","journal-title":"Hum. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/j.1460-2075.1986.tb04402.x","article-title":"Characterization of a human gene inducible by alpha- and beta-interferons and its expression in mouse cells.","volume":"5","author":"Kelly","year":"1986","journal-title":"EMBO J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1046\/j.1365-2893.1999.00189.x","article-title":"The core promoter of hepatitis B virus.","volume":"6","author":"Kramvis","year":"1999","journal-title":"J. Viral Hepat."},{"key":"B19","doi-asserted-by":"publisher","first-page":"11688","DOI":"10.1128\/jvi.76.22.11688-11703.2002","article-title":"Age-Dependent Resistance to Lethal Alphavirus Encephalitis in Mice: Analysis of Gene Expression in the Central Nervous System and Identification of a Novel Interferon-Inducible Protective Gene, Mouse ISG12.","volume":"76","author":"Labrada","year":"2002","journal-title":"J. Virol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00749","article-title":"Interferon-lambda: A potent regulator of intestinal viral infections.","volume":"8","author":"Lee","year":"2017","journal-title":"Front. Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1002\/hep.22881","article-title":"Hepatitis B: The virus and disease.","volume":"49","author":"Liang","year":"2009","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1872-034X.2007.00142.x","article-title":"Anti-hepatitis C virus activity of albinterferon alfa-2b in cell culture.","volume":"37","author":"Liu","year":"2007","journal-title":"Hepatol. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.virol.2014.06.014","article-title":"ISG12a mediates cell response to Newcastle disease viral infection.","author":"Liu","year":"2014","journal-title":"Virology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1128\/jvi.02463-15","article-title":"The Interferon-Stimulated Gene Ifi27l2a Restricts West Nile Virus Infection and Pathogenesis in a Cell-Type- and Region-Specific Manner.","volume":"90","author":"Lucas","year":"2016","journal-title":"J. Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1128\/jvi.01998-10","article-title":"Indoleamine 2,3-Dioxygenase Mediates the Antiviral Effect of Gamma Interferon against Hepatitis B Virus in Human Hepatocyte-Derived Cells.","volume":"85","author":"Mao","year":"2011","journal-title":"J. Virol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00609","article-title":"Type-I interferon responses: From friend to foe in the battle against chronic viral infection.","volume":"7","author":"Murira","year":"2016","journal-title":"Front. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/jgh.14986","article-title":"Antiviral activity of interferon-stimulated gene 20, as a putative repressor binding to hepatitis B virus enhancer II and core promoter.","volume":"35","author":"Park","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-5-8","article-title":"Identification of a novel gene family that includes the interferon-inducible human genes 6-16 and ISG12.","volume":"5","author":"Parker","year":"2004","journal-title":"BMC Genomics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1053\/jhep.1996.v23.ajhep0230909","article-title":"Actions of cytokines on the immune response and viral interactions: an overview.","volume":"23","author":"Peters","year":"1996","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.virol.2013.06.028","article-title":"Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha.","volume":"444","author":"Pollicino","year":"2013","journal-title":"Virology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/j.1460-2075.1988.tb02786.x","article-title":"Interferon response element of the human gene 6-16.","volume":"7","author":"Porter","year":"1988","journal-title":"EMBO J."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005893","article-title":"DNA Polymerase \u03ba Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.","volume":"12","author":"Qi","year":"2016","journal-title":"PLoS Pathog."},{"key":"B35","first-page":"4096","article-title":"Identification of a New Interferon-\u03b1-inducible Gene (p27) on Human Chromosome 14q32 and Its Expression in Breast Carcinoma.","volume":"53","author":"Rasmussen","year":"1993","journal-title":"Cancer Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11901-010-0055-1","article-title":"The role of interferon in hepatitis B therapy.","volume":"9","author":"Rijckborst","year":"2010","journal-title":"Curr. Hepat. Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1056\/nejm197611252952206","article-title":"The virus of hepatitis, type B (second of two parts)","volume":"295","author":"Robinson","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s10495-008-0190-0","article-title":"Mitochondrial localization and pro-apoptotic effects of the interferon-inducible protein ISG12a.","volume":"13","author":"Rosebeck","year":"2008","journal-title":"Apoptosis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions.","volume":"1","author":"Schoggins","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nature14554","article-title":"Erratum: A diverse range of gene products are effectors of the type I interferon antiviral response (Nature (2015) 472 (481-485) (doi: 10.1038\/nature09907))","volume":"525","author":"Schoggins","year":"2015","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1124\/pr.54.1.129","article-title":"Liver-enriched transcription factors in liver function and development. Part I: The hepatocyte nuclear factor network and liver-specific gene expression.","volume":"54","author":"Schrem","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1034\/j.1600-0528.2002.017404.x","article-title":"The liver as a crucial organ in the first line of host defense: The roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses.","volume":"174","author":"Seki","year":"2000","journal-title":"Immunol. Rev."},{"key":"B43","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R.","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/cmi.2016.67","article-title":"Type i IFN augments IL-27-dependent TRIM25 expression to inhibit HBV replication.","volume":"15","author":"Tan","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3551.e","DOI":"10.1016\/j.celrep.2019.11.041","article-title":"Type-I-IFN-Stimulated Gene TRIM5\u03b3 Inhibits HBV Replication by Promoting HBx Degradation.","volume":"29","author":"Tan","year":"2019","journal-title":"Cell Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1001\/jama.2018.3795","article-title":"Chronic Hepatitis B infection a review.","volume":"319","author":"Tang","year":"2018","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002159","article-title":"Effects of interferon-\u03b1\/\u03b2 on hbv replication determined by viral load.","volume":"7","author":"Tian","year":"2011","journal-title":"PLoS Pathog."},{"key":"B49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/jvh.12479","article-title":"Identification of FDA-approved drugs that target hepatitis B virus transcription.","volume":"23","author":"van de Klundert","year":"2016","journal-title":"J. Viral Hepat."},{"key":"B50","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.immuni.2006.08.008","article-title":"Fifty Years of Interferon Research: Aiming at a Moving Target.","volume":"25","author":"Vilcek","year":"2006","journal-title":"Immunity"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1128\/jvi.77.2.1227-1236.2003","article-title":"Searching for Interferon-Induced Genes That Inhibit Hepatitis B Virus Replication in Transgenic Mouse Hepatocytes.","volume":"77","author":"Wieland","year":"2003","journal-title":"J. Virol."},{"key":"B52","year":"2015","journal-title":"Guidelines for the prevention care and treatment of persons with chronic hepatitis B infection: Mar-15."},{"key":"B53","doi-asserted-by":"publisher","first-page":"6832","DOI":"10.1128\/jvi.00352-16","article-title":"ISG12a Restricts Hepatitis C Virus Infection through the Ubiquitination-Dependent Degradation Pathway.","volume":"90","author":"Xue","year":"2016","journal-title":"J. Virol."},{"key":"B54","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"B55","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1126\/science.2554495","article-title":"A liver-specific enhancer in the core promoter region of human hepatitis B virus.","volume":"246","author":"Yee","year":"1989","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.3748\/wjg.v17.i9.1152","article-title":"Hepatoma cell line HepG2.2.15 demonstrates distinct biological features compared with parental HepG2.","volume":"17","author":"Zhao","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"B57","first-page":"427","article-title":"[Updates of EASL clinical practice guidelines: management of chronic hepatitis B virus infection].","volume":"20","author":"Zhuang","year":"2012","journal-title":"Zhonghua Gan Zang Bing Za Zhi"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.656353\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T04:43:56Z","timestamp":1617165836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.656353\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":57,"alternative-id":["10.3389\/fmicb.2021.656353"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.656353","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,31]]},"article-number":"656353"}}